Cell Impact AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.838 million compared to SEK 18.03 million a year ago. Revenue was SEK 1.08 million compared to SEK 29.8 million a year ago. Net loss was SEK 37.52 million compared to SEK 28.93 million a year ago. Basic loss per share from continuing operations was SEK 0.18 compared to SEK 0.38 a year ago.

For the full year, the company reported sales was SEK 47.26 million compared to SEK 77.42 million a year ago. Revenue was SEK 48.58 million compared to SEK 93.03 million a year ago. Net loss was SEK 121.4 million compared to SEK 104.22 million a year ago. Basic loss per share from continuing operations was SEK 1.11 compared to SEK 1.38 a year ago.